Biotech

Theravance Biopharma to Present at the Baird 2016 Global Healthcare Conference

DUBLIN, IRELAND: ...

Hemostemix Inc. Reminds Shareholders to Vote the WHITE Proxy in Favour of the Current Trusted Board

TORONTO, ONTARIO: ...

Immunovaccine to Present at 2016 Rodman & Renshaw Global Investment Conference

HALIFAX, NOVA SCOTIA: ...

Trillium Therapeutics Introduces Industry Postdoctoral Fellowship Program

TORONTO, ONTARIO: ...

Hemostemix Voids Taiwanese Agreement

TORONTO, ONTARIO: ...

Hemostemix Issues Letter to Shareholders Urging Them to Vote Their WHITE Proxy

TORONTO, ONTARIO: ...

Atossa Genetics Announces Reverse Stock Split

SEATTLE, WA: 1:15 Reverse Stock Split Effective August 26, 2016 ...

Immunovaccine Announces Additional Positive Topline Results from Phase 1/1b Clinical Trial Program With DPX-Survivac in Ovarian Cancer

HALIFAX, NOVA SCOTIA: Data Reinforces Favorable Safety Profile, Robust Immunogenicity of Company's Lead Cancer Therapy Candidate, and Highlights Optimal Dosing Schedule ...

Ceapro Inc. Reports Second Quarter 2016 Financial and Operational Results

EDMONTON, ALBERTA: - Ceapro completes another record-setting quarter for the highest quarterly revenues reported in Company's history - Clinical program with avenanthramides as anti-inflammatory compound initiated ...

VBI Vaccines to Continue Enrolling Participants in the Phase I Trial of its Preventative Cytomegalovirus Vaccine Candidate Following Successful Data Safety Monitoring Board Review

CAMBRIDGE, MASSACHUSETTS: ...